Please assess the completion status of the following clinical trial:

Trial Title: Augmented Care at Worksite for Diabetes Prevention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Benefits-eligible Ohio State University (OSU) employee~2. Intend to be employed by OSU through the length of the follow-up phase~3. Body mass index: \>24 kg/m\^2 non-Asians; \>22 kg/m\^2 Asians~4. Fasting blood glucose of 100-125 mg/dL or an A1c of 5.7-6.4%~5. Blood glucose of 110-199 (if non-fasting in previous 2 hours)~Exclusion Criteria:~1. Blood glucose level of ≥ 200 mg/dL~2. Conditions that would limit adoption of light/moderate physical activity (i.e., cardiac event, severe chronic obstructive pulmonary disease, advanced arthritis, poorly controlled hypertension)~3. Chronic use of medications that affect blood glucose levels (i.e., corticosteroids)~4. Concurrent participation in a structured weight loss program or counseling for bariatric surgery~5. Pregnant or breastfeeding~6. Score of ≥ 10 on the Patient Health Questionnaire-8 indicating moderate to severe depressive symptoms~7. Score of ≥ 27 on the Binge Eating Scale indicating the potential for binge eating~8. Unwilling to accept randomization~9. Planning to move from the area or changing employment.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group Lifestyle Balance (GLB) (Type: ACTIVE_COMPARATOR): Standard lifestyle intervention to promote weight loss
- Group Lifestyle Balance Plus (GLB+) (Type: EXPERIMENTAL): Augmented lifestyle intervention for early slow responders

Based on this trial design, predict the completion outcome and termination type (if applicable).